Historique de carrière de Sandeep C. Kulkarni
Anciens postes connus de Sandeep C. Kulkarni
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOVANT, INC. | Directeur des opérations | 01/10/2018 | 01/12/2019 |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Directeur des opérations | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Operating Officer | 2 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Sandeep C. Kulkarni
- Expérience